Cargando…
Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice
BACKGROUND: Growth hormone (GH) is an essential regulator of intrahepatic lipid metabolism by activating multiple complex hepatic signaling cascades. Here, we examined whether chronic exogenous GH administration (via gene therapy) could ameliorate liver steatosis in animal models of alcoholic fatty...
Autores principales: | Qin, Ying, Tian, Ya-ping |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994817/ https://www.ncbi.nlm.nih.gov/pubmed/21087523 http://dx.doi.org/10.1186/1479-5876-8-120 |
Ejemplares similares
-
Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats
por: Qin, Ying, et al.
Publicado: (2010) -
Mitotherapy for Fatty Liver by Intravenous Administration of Exogenous Mitochondria in Male Mice
por: Fu, Ailing, et al.
Publicado: (2017) -
Molecular mechanism of alcoholic fatty liver
por: Rasineni, Karuna, et al.
Publicado: (2012) -
Growth hormone and nonalcoholic fatty liver disease
por: Ma, Ingrid L., et al.
Publicado: (2023) -
Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics
por: Yang, Huan, et al.
Publicado: (2023)